One eye supplement claim is proven: in people already diagnosed with intermediate age-related macular degeneration, the AREDS2 formula — vitamin C 500 mg, vitamin E 400 IU, zinc 80 mg, copper 2 mg, lutein 10 mg, zeaxanthin 2 mg — cuts the risk of progression to advanced AMD by about 25% over five years. The same research shows no prevention in healthy eyes and no benefit for cataract. Beyond that: omega-3 has modest, mixed evidence for dry-eye comfort (and failed for AMD); bilberry's night-vision fame traces to war propaganda, not trials; nothing dissolves floaters or "restores" vision. Most "vision support" blends copy AREDS2's ingredients at fractions of its doses for populations it never helped.
The one proven claim
The AREDS trials — NEI-run, thousands of participants, placebo-controlled, two decades — established that in diagnosed intermediate AMD (or advanced AMD in one eye), the AREDS2 formula reduces progression to advanced disease by roughly 25% over five years, with the lutein/zeaxanthin version safe for smokers. This is the genuine article: a supplement outcome large, replicated and specific enough that eye doctors prescribe it.
Its boundaries, from the same trials: no prevention in healthy or early-stage eyes, no cataract benefit, and no claim to restore vision already lost. A formula, a dose, a diagnosis — remove any of the three and the evidence stays behind.
The rest of the shelf
| Claim / ingredient | Verdict | What the evidence shows |
|---|---|---|
| AREDS2 formula, intermediate AMD | Moderate-strong | The ~25% progression reduction above — the aisle's one earned claim. |
| Lutein/zeaxanthin alone, healthy eyes | Insufficient | Diet associations; no prevention trials. Eat the greens. |
| Omega-3 for AMD | Negative | AREDS2 tested it directly: no added benefit. |
| Omega-3 for dry eye | Mixed | DREAM trial negative; smaller studies positive; a low-risk maybe behind standard care. |
| Bilberry / anthocyanins | Insufficient | Wartime folklore; trials small and negative for night vision. |
| Vitamins for cataract | Insufficient | Large trials (incl. AREDS) found no prevention; surgery remains the cure. |
| "Floater dissolving" formulas | Insufficient | No mechanism, no trials; floaters have rules of their own. |
| Blue-light/screen "protection" blends | Insufficient | Weak premise, tiny industry studies. |
| Bilateral "vision restoration" products | None | Claims of regrowing vision have no supporting trials — and mark the sellers worth avoiding entirely. |
| Ginkgo, saffron, astaxanthin, CoQ10 for eyes | Insufficient | Pilot-scale studies (saffron's are interesting and tiny); nothing decision-grade. |
Diabetic eye disease deserves its own line: no supplement treats or prevents diabetic retinopathy — glucose, blood pressure and screening do, and products implying otherwise are dangerous in the specific sense of delaying the exams that save sight.
Why the borrowing works commercially
AREDS2 gave the category a halo: real government trials, quotable percentages, ophthalmologist vocabulary. A typical "vision support" blend copies the ingredient names at a fraction of the doses (lutein 2 mg where the trial used 10; zinc 5 mg for 80), adds bilberry for romance, and sells to healthy-eyed screen users the trials never touched. The label comparison in the FAQ takes ninety seconds and sorts the entire shelf — a test our eye supplement product research runs on each product by name.
The honest playbook
- Over 50, or any AMD family history: the dilated exam is the intervention — it stages AMD (and finds glaucoma and diabetic disease) years before symptoms.
- Diagnosed intermediate AMD: a faithful AREDS2 formula, agreed with your eye doctor, plus smoking cessation and the Mediterranean-leaning plate.
- Healthy eyes: spinach, kale, eggs, fish, sunglasses, and glucose/blood-pressure care — the capsule version of this list does not exist.
- Dry, tired screen eyes: blink breaks, lid care, artificial tears, humidity; omega-3 as the optional maybe.
- New floaters, flashes, distortion or field loss: same-day rules, never a supplement decision.
Frequently asked questions
How do I check whether a product is a real AREDS2 formula?
Read the panel against the trial numbers — C 500 mg, E 400 IU, zinc 80 mg (as oxide; 25 mg was also tested and works), copper 2 mg, lutein 10 mg, zeaxanthin 2 mg, and no beta-carotene. Anything materially below those doses, padded with herbs, or labelled "based on AREDS2" while departing from it is a borrower. Faithful versions exist from several major brands at modest prices.
My optician said my AMD is early, not intermediate — should I take it anyway?
AREDS found no benefit at early stages, so guidelines don't recommend the formula there; the plan is diet, smoking cessation, and monitored exams so the intermediate stage — where the formula earns its 25% — is caught when it arrives. Taking it early wastes little but money and the zinc's minor stomach tax; the exam schedule is what actually protects you.
What about bilberry for night vision?
The legend comes from WWII RAF disinformation (cover stories for radar) and it has outlived the war by eighty years. Controlled trials of bilberry for night vision are few, small and essentially negative. It is a pleasant berry with anthocyanins and no demonstrated visual power.
Do omega-3 pills fix dry eye?
The largest independent trial (DREAM) found fish-oil capsules no better than placebo for dry-eye symptoms, after smaller positive studies. Some patients and clinicians still report individual benefit and the risk is low, so it survives as a legitimate maybe — behind the measures that reliably work: lids, drops, environment, screen-blink habits.
References
- JAMA. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the AREDS2 randomized clinical trial (2013). PubMed PMID 23644932. https://pubmed.ncbi.nlm.nih.gov/23644932/
- National Eye Institute. Age-Related Macular Degeneration (AMD) (2024). https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/age-related-macular-degeneration
- U.S. Food and Drug Administration. Dietary Supplements (2024). https://www.fda.gov/food/dietary-supplements
This page discusses supplement ingredients or categories. It may mention a commercial product, with disclosure. It is general health information, not personal medical advice. Read our editorial policy and medical review policy.